کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5622020 1579188 2017 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data
ترجمه فارسی عنوان
روند ترومبوفیلاکسیس و عوارض بعد از عمل جراحی ارتوپدی اندام تحتانی در کره: اطلاعات مورد نیاز در مورد بیمه بهداشت کشور
کلمات کلیدی
داروی ضد انعقاد دستورالعمل شکستگی لگن، خونریزی ترومبوآمبولی وریدی،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- The overall prescription rate for VTE prophylaxis has increased since 2008 in Korea.
- Prescription rate of NOACs following THA and TKA has drastically increased.
- Prescription rate of NOACs has increased little after HFS since 2010.
- Postoperative complications increased significantly only in HFS.

BackgroundIn Western countries, prophylaxis for venous thromboembolism (VTE) following major lower limb orthopaedic surgeries is recommended. However, that has not been the case in Asian countries, where the reported incidence of postoperative VTE has been low. The present study examined trends in VTE prophylaxis prescriptions and related complications following major lower limb orthopaedic surgeries in South Korea.Design/ParticipantsUsing claim data from the National Health Insurance Corporation, 263,664 patients aged 65 years or older who underwent major orthopaedic surgeries (total hip arthroplasty [THA], total knee arthroplasty [TKA], or hip fracture surgery [HFS]) between 2008 and 2012 were included.ResultThe prescription rate for VTE prophylaxis has increased from 62.4% in 2008 to 75.4% in 2012 (P < 0.001). The prescription rate for new oral anticoagulants following THA and TKA has increased drastically since 2010, while that following HFS has not. Instead, prophylactic use of aspirin or low molecular weight heparin has increased in HFS cases. The rate of postoperative complications has significantly increased annually only in HFS: VTE (P = 0.018) and brain haemorrhage or gastrointestinal bleeding (P = 0.019).ConclusionThis result could suggest the need for more studies about the use of VTE prophylactic medicines following HFS.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 155, July 2017, Pages 48-52
نویسندگان
, , , , ,